Among the TRPM subfamily, TRPM1 was the first identified in melanoma and is associated with tumor progression and survival, potentially through CaMKII-mediated activation of AKT signaling, thereby enhancing colony formation and tumor growth [168,169]. The gene discussed is AKT1; the disease is neoplasm.